# Hancock Whitney Corp: financial statements, quarterly

HWC · Nasdaq · CIK 750577 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hwc.md) · [Financials](/companies/hwc/financials.md) · [Filings](/companies/hwc/filings.md) · [Insiders](/companies/hwc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hwc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [147](/filings/0000950170-23-058447.md) | [157 d](/filings/0000950170-24-022252.md) | [156](/filings/0000950170-24-055917.md) | [157](/filings/0000950170-24-092942.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [24.3](/filings/0000950170-24-123302.md) | [11.7 d](/filings/0001193125-26-077903.md) | [24.7](/filings/0000950170-25-067254.md) | [30.3](/filings/0000950170-25-105138.md) | [29.7](/filings/0001193125-25-265159.md) | [28.4 d](/filings/0001193125-26-077903.md) | [29.7](/filings/0001193125-26-212425.md) | [31.0](/filings/0001193125-26-338672.md) | [32.9](/filings/0001193125-25-265159.md) | [32.7 d](/filings/0001193125-26-077903.md) | [11.3](/filings/0001193125-26-212425.md) | [35.2](/filings/0001193125-26-338672.md) |
| Net income | $m | [97.7](/filings/0000950170-24-123302.md) | [50.6 d](/filings/0001193125-26-077903.md) | [109](/filings/0000950170-25-067254.md) | [115](/filings/0000950170-25-105138.md) | [116](/filings/0001193125-25-265159.md) | [122 d](/filings/0001193125-26-077903.md) | [120](/filings/0001193125-26-212425.md) | [114](/filings/0001193125-26-338672.md) | [127](/filings/0001193125-25-265159.md) | [126 d](/filings/0001193125-26-077903.md) | [47.4](/filings/0001193125-26-212425.md) | [127](/filings/0001193125-26-338672.md) |
| Diluted EPS | $ per share | [1.12](/filings/0000950170-24-123302.md) | not reported | [1.24](/filings/0000950170-25-067254.md) | [1.31](/filings/0000950170-25-105138.md) | [1.33](/filings/0001193125-25-265159.md) | not reported | [1.38](/filings/0001193125-26-212425.md) | [1.32](/filings/0001193125-26-338672.md) | [1.49](/filings/0001193125-25-265159.md) | not reported | [0.57](/filings/0001193125-26-212425.md) | [1.55](/filings/0001193125-26-338672.md) |
| Basic EPS | $ per share | [1.12](/filings/0000950170-24-123302.md) | not reported | [1.25](/filings/0000950170-25-067254.md) | [1.31](/filings/0000950170-25-105138.md) | [1.33](/filings/0001193125-25-265159.md) | not reported | [1.38](/filings/0001193125-26-212425.md) | [1.32](/filings/0001193125-26-338672.md) | [1.50](/filings/0001193125-25-265159.md) | not reported | [0.58](/filings/0001193125-26-212425.md) | [1.56](/filings/0001193125-26-338672.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [36.3](/filings/0000950170-23-058447.md) | [35.6](/filings/0000950170-25-028009.md) | [35.2](/filings/0000950170-24-055917.md) | [35.4](/filings/0000950170-24-092942.md) | [35.2](/filings/0000950170-24-123302.md) | [35.1](/filings/0001193125-26-077903.md) | [34.8](/filings/0000950170-25-067254.md) | [35.2](/filings/0000950170-25-105138.md) | [35.8](/filings/0001193125-25-265159.md) | [35.5](/filings/0001193125-26-338672.md) | [35.5](/filings/0001193125-26-212425.md) | [36.3](/filings/0001193125-26-338672.md) |
| Total liabilities | $bn | [32.8](/filings/0000950170-23-058447.md) | [31.8](/filings/0000950170-25-028009.md) | [31.4](/filings/0000950170-24-055917.md) | [31.5](/filings/0000950170-24-092942.md) | [31.1](/filings/0000950170-24-123302.md) | [31.0](/filings/0001193125-26-077903.md) | [30.5](/filings/0000950170-25-067254.md) | [30.8](/filings/0000950170-25-105138.md) | [31.3](/filings/0001193125-25-265159.md) | [31.0](/filings/0001193125-26-338672.md) | [31.1](/filings/0001193125-26-212425.md) | [31.9](/filings/0001193125-26-338672.md) |
| Long-term debt | $bn | [0.2](/filings/0000950170-23-058447.md) | [0.2](/filings/0000950170-25-028009.md) | [0.2](/filings/0000950170-24-055917.md) | [0.2](/filings/0000950170-24-092942.md) | [0.2](/filings/0000950170-24-123302.md) | [0.2](/filings/0001193125-26-077903.md) | [0.2](/filings/0000950170-25-067254.md) | [0.2](/filings/0000950170-25-105138.md) | [0.2](/filings/0001193125-25-265159.md) | [0.2](/filings/0001193125-26-338672.md) | [0.2](/filings/0001193125-26-212425.md) | [0.2](/filings/0001193125-26-338672.md) |
| Short-term borrowings | $bn | [1.4](/filings/0000950170-23-058447.md) | [1.2](/filings/0000950170-25-028009.md) | [0.7](/filings/0000950170-24-055917.md) | [1.4](/filings/0000950170-24-092942.md) | [1.3](/filings/0000950170-24-123302.md) | [0.6](/filings/0001193125-26-077903.md) | [0.5](/filings/0000950170-25-067254.md) | [1.0](/filings/0000950170-25-105138.md) | [1.9](/filings/0001193125-25-265159.md) | [1.0](/filings/0001193125-26-338672.md) | [1.4](/filings/0001193125-26-212425.md) | [1.6](/filings/0001193125-26-338672.md) |
| Shareholders' equity | $bn | [3.5](/filings/0000950170-24-123302.md) | [3.8](/filings/0001193125-26-077903.md) | [3.9](/filings/0000950170-25-105138.md) | [3.9](/filings/0001193125-25-265159.md) | [4.2](/filings/0001193125-25-265159.md) | [4.1](/filings/0001193125-26-338672.md) | [4.3](/filings/0001193125-26-338672.md) | [4.4](/filings/0001193125-26-338672.md) | [4.5](/filings/0001193125-25-265159.md) | [4.5](/filings/0001193125-26-338672.md) | [4.4](/filings/0001193125-26-338672.md) | [4.4](/filings/0001193125-26-338672.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [188 d](/filings/0000950170-24-123302.md) | [92.8 d](/filings/0001193125-26-077903.md) | [167](/filings/0000950170-25-067254.md) | [105 d](/filings/0000950170-25-105138.md) | [162 d](/filings/0001193125-25-265159.md) | [192 d](/filings/0001193125-26-077903.md) | [104](/filings/0001193125-26-212425.md) | [126 d](/filings/0001193125-26-338672.md) | [159 d](/filings/0001193125-25-265159.md) | [153 d](/filings/0001193125-26-077903.md) | [114](/filings/0001193125-26-212425.md) | [151 d](/filings/0001193125-26-338672.md) |
| Capital expenditure | $m | [6.3 d](/filings/0000950170-24-123302.md) | [0.5 d](/filings/0001193125-26-077903.md) | [2.3](/filings/0000950170-25-067254.md) | [1.3 d](/filings/0000950170-25-105138.md) | [3.9 d](/filings/0001193125-25-265159.md) | [2.7 d](/filings/0001193125-26-077903.md) | [4.0](/filings/0001193125-26-212425.md) | [3.8 d](/filings/0001193125-26-338672.md) | [3.8 d](/filings/0001193125-25-265159.md) | [7.1 d](/filings/0001193125-26-077903.md) | [5.9](/filings/0001193125-26-212425.md) | [0.9 d](/filings/0001193125-26-338672.md) |
| Dividends paid | $m | [26.2 d](/filings/0000950170-24-123302.md) | [26.2 d](/filings/0001193125-26-077903.md) | [26.5](/filings/0000950170-25-067254.md) | [34.9 d](/filings/0000950170-25-105138.md) | [34.8 d](/filings/0001193125-25-265159.md) | [34.7 d](/filings/0001193125-26-077903.md) | [39.6](/filings/0001193125-26-212425.md) | [38.7 d](/filings/0001193125-26-338672.md) | [38.4 d](/filings/0001193125-25-265159.md) | [37.2 d](/filings/0001193125-26-077903.md) | [42.1](/filings/0001193125-26-212425.md) | [40.5 d](/filings/0001193125-26-338672.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-123302.md) | [0.0 d](/filings/0000950170-25-028009.md) | [0.0](/filings/0000950170-25-067254.md) | [14.6 d](/filings/0000950170-25-105138.md) | [15.2 d](/filings/0001193125-25-265159.md) | [7.9 d](/filings/0001193125-26-077903.md) | [20.7](/filings/0001193125-26-212425.md) | [39.4 d](/filings/0001193125-26-338672.md) | [40.1 d](/filings/0001193125-25-265159.md) | [147 d](/filings/0001193125-26-077903.md) | [94.6](/filings/0001193125-26-212425.md) | [46.5 d](/filings/0001193125-26-338672.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [86.0](/filings/0000950170-23-058447.md) | [86.3](/filings/0000950170-24-055917.md) | [86.4](/filings/0000950170-24-092942.md) | [86.4](/filings/0000950170-24-123302.md) | [86.7](/filings/0000950170-25-067254.md) | [86.8](/filings/0000950170-25-105138.md) | [86.6](/filings/0001193125-25-265159.md) | [86.5](/filings/0001193125-26-212425.md) | [85.9](/filings/0001193125-26-338672.md) | [85.5](/filings/0001193125-25-265159.md) | [82.3](/filings/0001193125-26-212425.md) | [81.5](/filings/0001193125-26-338672.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 80,223,058 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338672.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.